Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

SkinDermic secures licence

Satt IDF Innov has licenced research at Institut Cochin and Institut Pierre-Louis to SkinDemic, which will now commercialise a treatment for acne and Kaposi's sarcoma.

Apr 10, 2018

Arvinas balances $55m series C

Yale spinout Arvinas has added cash to its coffers as it prepares oncological treatments for forms of prostate and breast cancer.

Apr 10, 2018

Cogvis walks into $870,000 round

TU Wien spinout Cogvis has developed a contactless sensor that predicts when a person might fall and is aimed at the elderly care sector.

Apr 10, 2018

Constellation aligns with investors for $100m round

UC Investment Office, an existing Constellation backer, has returned to contribute to a $100m round that took its total equity funding to $229m.

Apr 10, 2018

Infinite Cooling wins top prize in Rice Business Plan Competition

Infinite Cooling, based on research at MIT, has won the $500,000 top prize in a competition involving 42 student-led startups

Apr 9, 2018

Big deal: Roche derives MS treatment

Versant's unusual build-to-buy model has resulted in Roche acquiring a target for MS based on UCSF research and the venture firm launching a new spinout, Pipeline Therapeutics.

Apr 9, 2018

Parkwalk diverts more cash to Oxford Endovascular

Parkwalk has invested in the spinout through both its Parkwalk Opportunities Fund and the University of Oxford Innovation Fund IV.

Apr 9, 2018

Origami powers up $26.3m round

Origami has welcomed a follow-on investment from Cambridge Innovation Capital as it prepares to take its energy management and control platform into international markets.

Apr 9, 2018

Inflowmatix collects funding

Parkwalk has contributed to a funding round for Inflomatix, a spinout from Imperial College London that previously closed a $4.3m series A round two years ago.

Apr 9, 2018

Microtech Ceramics forms $1.8m round

Imperial College London spinout Microtech Ceramics has received capital from investment firm Kero.

Apr 9, 2018

ITBMed secures $67m equity transplant

The immunomodulation therapy developer has been backed by Pablo Legorreta in the wake of a phase 2 trial of its therapy for organ transplant patients.

Apr 9, 2018
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here